Persistence and adherence, not efficacy claims alone, distinguish IL-23 biologics in practice. Real-world claims data reveal ...

Angela Fitch, MD, co-founder and chief medical officer of Knownwell and past president of the Obesity Medicine Association, ...

Recently, a significant breakthrough was achieved when 42 international vitiligo experts and 4 patient representatives collaborated and developed a consensus management strategy for vitiligo. Until ...

Galderma announced an agreement to acquire ZO Skin Health for an enterprise value of $1.5 billion, a move designed to expand ...

An analysis of 633 skincare brands found gaps in evidence, safety information, and claim support, raising questions about ...

Christopher Bunick, MD, PhD, reviews data on investigational atopic dermatitis agents presented at EADV 2026 and biomarker ...

Across social media, castor oil is frequently promoted as a natural solution for thinning hair, sparse eyebrows, and slow hair growth. Users massage the thick oil directly into th ...

Sequencing Cryotherapy, Topicals, and PDT in Actinic Keratosis. Bhatia said comprehensive management of actinic keratosis has ...

Remibrutinib is approved for chronic spontaneous urticaria (CSU) and most recently, symptomatic dermographism, with the label ...

In "Case 2: Escalating Therapy After Biologic Failure in HS," the panel shifts to the series' second patient case.

In "Recognizing EPP: Diagnostic Red Flags, Psychosocial Burden, and Confirmatory Workup," Dr. Bonkovsky turns to what should ...

Gelfand described psoriasis as an inflammatory metabolic disease. Among inflammatory diseases of medicine, he said psoriasis has by far the closest association with obesity. Obesity makes psoriasis ...